External

BBME seminar: "Learning from Small Data", Dr. Dan Nicolau Jr, Reader, King's College London

admin — Wed, 28 Jan 2026 18:08:16 +0000

Community Collaboration: Building Intersectoral Partnerships

monica.slanik@mcgill.ca — Tue, 09 Dec 2025 18:14:20 +0000

Join us for a look inside 10+ years of collaboration between Amar Seva Sangam and ��ɫֱ��’s School of Physical & Occupational Therapy.

Feindel Brain and Mind Seminar Series: Studying Memory for Natural Events Across Multiple Timescales

admin — Mon, 26 Jan 2026 16:07:28 +0000

The Feindel Brain and Mind Seminar Series will advance the vision of Dr. William Feindel (1918–2014), Former Director of the Neuro (1972–1984), to constantly bridge the clinical and research realms.

BBME seminar: "Co-Design of VR and Socially Assistive Interventions for Diverse Aging Communities", Harmehr Sekhon, PhD, Department of Medicine, Division of Geriatric Medicine, ��ɫֱ��

admin — Fri, 23 Jan 2026 16:40:46 +0000

Weston Family Foundation awards two ��ɫֱ�� researchers combatting neurodegenerative diseases of aging

admin — Thu, 22 Jan 2026 16:38:29 +0000

7th National Course on Sleep Medicine

admin — Wed, 21 Jan 2026 14:56:20 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

Neurogenesis Speaker Series: February Edition

admin — Mon, 19 Jan 2026 18:08:07 +0000

Come meet HBHL-supported Faculty!

PERL Launch Event: Health Crises in an Era of Autocracy, Disinformation, and Shifting Geopolitical Risks

admin — Fri, 16 Jan 2026 17:30:21 +0000

WHEN: Tuesday, February 3, 2026, 8:30 am - 4:00 pm
WHERE: ��ɫֱ�� Faculty Club Ballroom - 3450 rue McTavish, Montreal, QC

Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia

admin — Thu, 15 Jan 2026 14:02:20 +0000

A large ��ɫֱ�� study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.

The study examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.

Three ��ɫֱ�� researchers receive SSHRC Partnership Engage Grants

admin — Wed, 14 Jan 2026 16:32:44 +0000

PERL Launch Event: Health Crises in an Era of Autocracy, Disinformation, and Shifting Geopolitical Risks

admin — Thu, 11 Dec 2025 18:31:59 +0000

WHEN: Tuesday, February 3, 2026, 8:30 am - 4:00 pm

The 2026 Dr. Donald G. Doehring Memorial Lecture

admin — Tue, 13 Jan 2026 14:54:19 +0000

Thursday March 12 2026 • 4:30pm to 6pm
Dentistry Suite #102, 2001 Avenue ��ɫֱ�� College

Anna Papafragou, PhD
Professor • Department of Linguistics, University of Pennsylvania

Online Info Session: International Masters for Health Leadership (IMHL)

admin — Fri, 19 Dec 2025 14:25:27 +0000

Join our ��ɫֱ�� IMHL program team for a 30 minutes information session to learn how our module-based masters can help accelerate your leadership career in the healthcare sector.

Online Info Session: International Masters for Health Leadership (IMHL)

admin — Fri, 19 Dec 2025 14:26:29 +0000

Join our ��ɫֱ�� IMHL program team for a 30 minutes information session to learn how our module-based masters can help accelerate your leadership career in the healthcare sector.

Preparing Academic Investigators for Clinical Trial Readiness in Neurology

admin — Wed, 17 Dec 2025 15:48:16 +0000

The team from the Platform for Advanced Clinical Therapies (PACT) and Investigator-Initiated Trials (IIT) at The Neuro’s Clinical Research Unit will help academic researchers better understand the regulatory, ethical and legal requirements to tran